Physician profile
Eric T Kitzmann
NPI 1134500200
$2,035.15
in general payments reported to CMS, 2019-2025
18 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $130 · 2021: $274 · 2022: $314 · 2023: $258 · 2024: $506 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,071 · Entertainment: $21.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,071.32 |
| Entertainment | $21.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $540.21 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $311.83 | 2022-2025 | Miebo, Xiidra, Infuse |
| Glaukos Corporation | $246.91 | 2019-2024 | Photrexa |
| Alcon Vision LLC | $191.75 | 2019-2025 | Precision7, Tryptyr |
| Oyster Point Pharma, INC. | $174.20 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Coopervision INC. | $96.36 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Tarsus Pharmaceuticals, INC. | $92.09 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $69.23 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $54.90 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $43.81 | 2020-2021 | |
| Allergan, INC. | $37.28 | 2019-2021 | |
| Abb Con-Cise Optical Group LLC | $35.93 | 2022-2025 | Contact Lens |
| Lkc Technologies, INC. | $32.22 | 2025 | |
| Abbvie INC. | $25.43 | 2023 | |
| Rxsight INC | $25.26 | 2024 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $21.96 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Kala Pharmaceuticals, INC. | $21.70 | 2021 | |
| Shire North American Group INC | $14.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Kitzmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.